Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide—the injectable medication originally developed for type 2 diabetes—has become one of the most sought-after weight loss treatments in the United States. Clinical trials show that patients using semaglutide lose an average of 14% of their body weight over 68 weeks, but accessing the medication safely requires understanding your options. This guide explains where semaglutide is available, what makes a source legitimate, and how PlexusDx simplifies the process for patients in all states.
Why Semaglutide Access Has Become Challenging
Ozempic and Wegovy—brand-name semaglutide products—have faced significant supply shortages since 2022, making prescription fills unpredictable and expensive. Many patients report waiting months for refills or paying out-of-pocket costs exceeding $900 per month when insurance denies coverage. This scarcity created demand for alternative access routes, including compounded versions of semaglutide from licensed pharmacies.
The FDA does not regulate compounded medications the same way it regulates brand-name drugs, but compounded semaglutide from 503A pharmacies meets strict state pharmacy board standards. A 503A pharmacy compounds medications in small batches for individual patients, unlike 503B facilities that produce large quantities for distribution. PlexusDx partners exclusively with licensed 503A compounding pharmacies to ensure every dose meets quality and sterility benchmarks.
Understanding Your Semaglutide Access Options
Patients seeking semaglutide have three main sources: traditional retail pharmacies filling brand-name prescriptions, compounding pharmacies, and telehealth platforms that coordinate both prescription and medication delivery. Retail pharmacies often cannot stock sufficient inventory, and insurance coverage remains inconsistent across plans. Compounding pharmacies and telehealth services typically offer faster turnaround, lower upfront costs, and no insurance requirement—making them the practical choice for many weight loss patients.
PlexusDx operates as a telehealth provider that pairs medical evaluation with compounded semaglutide from licensed 503A pharmacies. Your dose may need to go up over time as your body adjusts, but your price won't—PlexusDx charges a flat monthly rate starting at $149, regardless of which dose level your provider recommends. This pricing model removes the financial barrier to dose optimization that many patients face with traditional pharmacy fills.
Safety Standards for Compounded Semaglutide
Licensed 503A compounding pharmacies must comply with USP (United States Pharmacopeia) standards for sterility, potency, and labeling. State pharmacy boards conduct inspections and enforce strict contamination protocols, and each batch undergoes potency verification before dispensing. These safeguards mean compounded semaglutide is formulated to match the pharmaceutical grade of brand-name products, despite not carrying FDA approval.
When evaluating any semaglutide source—whether compounded or brand-name—verify that your pharmacy holds current state licensure and that your prescribing provider is licensed and credentialed. Avoid unverified online retailers, international mail-order services, or direct-to-consumer sites that do not disclose their pharmacy credentials. PlexusDx providers review your medical history before prescribing, your medications ship from licensed U.S. pharmacies, and you receive ongoing clinical support throughout treatment.
How PlexusDx Personalizes Your Semaglutide Experience
Not every patient responds identically to semaglutide—genetic differences in GLP-1 receptor sensitivity, appetite-signaling pathways, and metabolic rate influence both weight loss outcomes and side effect tolerance. PlexusDx offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify your unique peptide pathway profile across 14 metabolic pathways and 150+ genetic insights. Testing reveals your predisposition for GLP-1 receptor responsiveness and other factors that inform optimal medication selection and dosing strategy.
Your PlexusDx medical provider uses genetic and clinical data to recommend semaglutide, tirzepatide, or a dual-compound protocol tailored to your metabolism. Compounded semaglutide injections start at $149 monthly, and the flat-rate pricing applies whether you're at a lower starter dose or a higher maintenance dose. This approach prioritizes efficacy and tolerability over cost, ensuring you reach the dose your body needs without financial friction.
Comparing Semaglutide Delivery Methods
Semaglutide is available as a subcutaneous injection (administered once weekly) or as an oral tablet (dosed daily). Injection forms—both brand-name and compounded—deliver higher bioavailability and more consistent blood levels, which translates to more predictable weight loss results in clinical practice. Oral semaglutide requires higher doses to achieve similar effects and may cause more gastrointestinal side effects, though it appeals to patients who prefer tablets over needles.
PlexusDx offers compounded semaglutide injection (starting at $149/mo) and oral semaglutide (starting at $249/mo), allowing you to choose the delivery method that fits your lifestyle and preferences. Many patients find that once-weekly injections fit more easily into their routine than daily pills, and the injection format aligns with how the medication was originally studied in weight loss trials. Your provider will discuss both options during your initial consultation and can switch methods if needed as your treatment progresses.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is compounded semaglutide as safe as brand-name Ozempic or Wegovy?
Compounded semaglutide from licensed 503A pharmacies meets rigorous sterility and potency standards set by state pharmacy boards and USP guidelines. While compounded medications lack FDA approval, they are legally prescribed and clinically equivalent in strength when sourced from credentialed pharmacies. PlexusDx ensures every patient receives semaglutide from licensed 503A compounding pharmacies and maintains medical oversight throughout treatment.
How much weight can I expect to lose with semaglutide?
Clinical trials show that patients using semaglutide lose an average of 14% of their baseline body weight over approximately 16 months of treatment. Individual results vary based on genetics, lifestyle adherence, and baseline metabolic rate—factors that PlexusDx's Precision Peptide Genetic Test can help clarify. Your provider will set realistic expectations and monitor your progress to ensure your dose is optimized for your body.
How much does semaglutide cost through PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month on a flexible commitment tier, with no insurance required and HSA/FSA eligibility. Your dose may need to go up over time, but your price won't—the flat monthly rate applies regardless of dose level. There are no membership fees, and all 50 states are served with direct-to-home shipping.
What side effects should I expect from semaglutide?
The most common side effects are gastrointestinal, including nausea, vomiting, constipation, and reduced appetite—which often subside within 2–4 weeks as your body adjusts. Serious adverse events (pancreatitis, severe dehydration) are rare but require immediate medical attention. PlexusDx providers screen for contraindications before prescribing and provide ongoing monitoring to manage side effects and adjust your dose safely.
How does the Precision Peptide Genetic Test help with semaglutide treatment?
The Precision Peptide Genetic Test identifies your genetic variants in GLP-1 receptor function, appetite-signaling pathways, and metabolic genes that influence semaglutide efficacy and tolerability. Results guide your provider in selecting the right medication and dose level for your unique biology, reducing trial-and-error and improving outcomes. The test costs $99 as an add-on after your first month of treatment and maps 14 pathways across 150+ genetic insights.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do the Side Effects of Wegovy Go Away?
Navigating Nausea: What to Expect When Taking Ozempic and Eating